Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective of this study is to assess the clinical efficacy of IPH1101 (with low-dose IL 2, as aldesleukin), administered in combination with a standard course of rituximab, in patients with Follicular Lymphoma having relapsed after at least one prior rituximab-containing line.
Inclusion criteria
- Follicular lymphoma